Whole Brain Imaging of HIV-Infected Patients: Quantitative Analysis of Magnetization Transfer Ratio Histogram and Fractional Brain Volume

References

1. ↵
   Heyes MP, Jordan EK, Lee K, et al. Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid. Brain Res 1992;570:237–250

   CrossRefPubMedWeb of Science
2. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 1993;45:309–379

   Abstract
3. ↵
   Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 1992;66:285–291

   PubMedWeb of Science
4. ↵
   Pemberton LA, Kerr SJ, Smythe G, Brew BJ. Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. J Interferon Cytokine Res 1997;17:589–595

   PubMedWeb of Science
5. ↵
   Masliah E, Ge N, Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit Rev Neurobiol 1996;10:57–67

   PubMedWeb of Science
6. Kerr SJ, Armati PJ, Guillemin GJ, Brew BJ. Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS 1998;12:355–363

   PubMedWeb of Science
7. ↵
   Heyes MP, Ellis RJ, Ryan L, et al. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 2001;124:1033–1042

   Abstract/FREE Full Text
8. ↵
   Gendelman HE, Lipton SA, Epstein L, Swindells S. HIV neurocognitive disorders. In: Gendelman HE, Lipton SA, Epstein L, Swindells S, eds. The Neurology of AIDS. New York: Chapman and Hall;1998 :499–523
9. ↵
   Kieburtz K, Ketonen L, Cox C, et al. Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. Arch Neurol 1996;53:155–158

   CrossRefPubMedWeb of Science
10. ↵
    Aylward EH, Henderer JD, McArthur JC, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993;43:2099–2104

    Abstract/FREE Full Text
11. ↵
    Aylward EH, Brettschneider PD, McArthur JC, et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 1995;152:987–994

    PubMedWeb of Science
12. ↵
    McArthur JC, Sacktor N, Selnes O. Human immunodeficiency virus-associated dementia. Semin Neurol 1999;19:129–150

    CrossRefPubMedWeb of Science
13. ↵
    Udupa JK, Samarasekera S. Fuzzy connectedness and object definition: theory, algorithms and applications in imaging segmentation. Graph Models Image Proc 1996 :480–489
14. ↵
    Udupa JK, Odhner D, Samarasekera S. 3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system. Proc SPIE 1994 :58–73
15. ↵
    Udupa JK, Wei L, Samarasekera S, Miki Y, van Buchem MA, Grossman RI. Multiple sclerosis lesion quantification using fuzzy-connectedness principles. IEEE Trans Med Imaging 1997;16:598–609

    CrossRefPubMedWeb of Science
16. ↵
    Ge Y, Grossman RI, Udupa JK, et al. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 2000;214:665–670

    PubMedWeb of Science
17. ↵
    Woods R, Mazziotta J, Cherry S. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536–546

    CrossRefPubMedWeb of Science
18. ↵
    Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging [published erratum appears in Radiology 1992;183:878]. Radiology 1992;182:483–491

    PubMedWeb of Science
19. ↵
    Dousset V, Armand JP, Lacoste D, et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy: Groupe d’Epidemiologie Clinique du SIDA en Aquitaine. AJNR Am J Neuroradiol 1997;18:895–901

    Abstract/FREE Full Text
20. ↵
    Filippi CG, Ulug AM, Ryan E, Ferrando SJ, van Gorp W. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol 2001;22:277–283

    Abstract/FREE Full Text
21. ↵
    Stout JC, Ellis RJ, Jernigan TL, et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study: HIV Neurobehavioral Research Center Group. Arch Neurol 1998;55:161–168

    CrossRefPubMedWeb of Science
22. ↵
    Brightbill TC, Post MJ, Hensley GT, Ruiz A. MR of Toxoplasma encephalitis: signal characteristics on T2-weighted images and pathologic correlation. J Comput Assist Tomogr 1996;20:417–422

    CrossRefPubMed
23. ↵
    Thurnher MM, Thurnher SA, Schindler E. CNS involvement in AIDS: spectrum of CT and MR findings. Eur Radiol 1997;7:1091–1097

    CrossRefPubMed
24. ↵
    Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999;52:995–1003

    Abstract/FREE Full Text
25. ↵
    Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study [published erratum appears in Neurology 1996;46:1787]. Neurology 1996;46:783–788

    FREE Full Text
26. ↵
    Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673–676

    CrossRefPubMedWeb of Science
27. ↵
    Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809–814

    CrossRefPubMedWeb of Science
28. ↵
    Leary SM, Silver NC, Stevenson VL, Barker GJ, Miller DH, Thompson AJ. Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis. Mult Scler 1999;5:313–316

    Abstract/FREE Full Text
29. ↵
    Pike GB. Magnetization transfer imaging of multiple sclerosis. Ital J Neurol Sci 1997;18:359–365

    CrossRefPubMed
30. ↵
    Suwanwelaa N, Phanuphak P, Phanthumchinda K, et al. Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn Reson Imaging 2000;18:859–865

    CrossRefPubMedWeb of Science
31. ↵
    Broderick DF, Wippold FJ, Clifford DB, Kido D, Wilson BS. White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR Am J Roentgenol 1993;161:177–181

    PubMed
32. ↵
    Patel SH, Kolson DL, Glosser G, et al. Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. AJNR Am J Neuroradiol 2002;23:543–549

    Abstract/FREE Full Text
33. ↵
    Sardar AM, Hutson PH, Reynolds GP. Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport 1999;10:3513–3515

    PubMedWeb of Science
34. ↵
    Heindel WC, Jernigan TL, Archibald SL, Achim CL, Masliah E, Wiley CA. The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol 1994;51:1129–1135

    CrossRefPubMedWeb of Science
35. ↵
    Dooneief G, Bello J, Todak G, et al. A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection. Arch Neurol 1992;49:38–43

    CrossRefPubMedWeb of Science
36. ↵
    van Buchem MA, Udupa JK, McGowan JC, et al. Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. AJNR Am J Neuroradiol 1997;18:1287–1290

    Abstract
37. ↵
    Elovaara I, Poutiainen E, Raininko R, et al. Mild brain atrophy in early HIV infection: the lack of association with cognitive deficits and HIV-specific intrathecal immune response. J Neurol Sci 1990;99:121–136

    CrossRefPubMedWeb of Science